Teasing Out the Interplay Between Natural Killer Cells and Nociceptor Neurons

Summary

Nociceptor neurons and NK cells actively interact in an inflammatory context. A co-culture approach enables studying this interplay.

Abstract

Somatosensory neurons have evolved to detect noxious stimuli and activate defensive reflexes. By sharing means of communication, nociceptor neurons also tune host defenses by controlling the activity of the immune system. The communication between these systems is mostly adaptive, helping to protect homeostasis, it can also lead to, or promote, the onset of chronic diseases. Both systems co-evolved to allow for such local interaction, as found in primary and secondary lymphoid tissues and mucosa. Recent studies have demonstrated that nociceptors directly detect and respond to foreign antigens, immune cell-derived cytokines, and microbes.

Nociceptor activation not only results in pain hypersensitivity and itching, but lowers the nociceptor firing threshold, leading to the local release of neuropeptides. The peptides that are produced by, and released from, the peripheral terminals of nociceptors can block the chemotaxis and polarization of lymphocytes, controlling the localization, duration, and type of inflammation. Recent evidence shows that sensory neurons interact with innate immune cells via cell-cell contact, for example, engaging group 2D (NKG2D) receptors on natural killer (NK) cells.

Given that NK cells express the cognate receptors for various nociceptor-produced mediators, it is conceivable that nociceptors use neuropeptides to control the activity of NK cells. Here, we devise a co-culture method to study nociceptor neuron-NK cell interactions in a dish. Using this approach, we found that lumbar nociceptor neurons decrease NK cell cytokine expression. Overall, such a reductionist method could be useful to study how tumor-innervating neurons control the anticancer function of NK cells and how NK cells control the elimination of injured neurons.

Introduction

The cell bodies of sensory neurons originate in the dorsal root ganglia (DRG). The DRG are located in the peripheral nervous system (PNS), between the dorsal horn of the spinal cord and the peripheral nerve terminals. The pseudo-unipolar nature of DRG neurons allows the transfer of information from the peripheral branch, which innervates the target tissue, to the central branch, which carries the somatosensory information to the spinal cord¹. Using specialized ion channel receptors, first-order neurons sense threats posed by pathogens, allergens, and pollutants², leading to the influx of cations (Na⁺, Ca²⁺) and the generation of an action potential^3,4,⁵.

These neurons also send antidromic action potential toward the periphery, where the initial danger sensing had occurred, which leads to the local release of neuropeptides^1,4. Therefore, the nociceptor neurons serve as a protective mechanism, alerting the host to environmental danger^4,5,6,7. 

To communicate with second-order neurons, the nociceptors release various neurotransmitters (e.g., glutamate) and neuropeptides (e.g., calcitonin gene-related peptide (CGRP), substance P (SP), and vasoactive intestinal peptide (VIP))^6,7.These peptides act on capillaries and promote plasma extravasation, edema, and the local influx and modulation of immune cells^2,4,7.

The somatosensory and immune systems utilize a shared communication system composed of cytokines and neuropeptides, and their respective cognate receptors⁴. While this bidirectional communication helps protect from danger and preserve homeostasis, it can also contribute to disease pathophysiology⁴. 

NK cells are classified as innate lymphoid cells and are specialized to eliminate virally infected cells. NK cell function is governed by a balance of stimulatory and inhibitory receptors, including the activating receptor NKG2D⁸. The endogenous ligand of NKG2D, retinoic acid early inducible1 (RAE1), is expressed by cells undergoing stress such as tumorigenesis and infection^8,9.

Recent investigations have shown that peripheral nerve injury drives sensory neurons to express maladaptive molecules such as stathmin 2 (STMN2) and RAE1. Thus, via cell-cell contact, NKG2D-expressing NK cells were activated by interaction with RAE1-expressing neurons. In turn, NK cells were able to eliminate injured nociceptor neurons and blunt pain hypersensitivity normally associated with nerve injury¹⁰. In addition to the NKG2D-RAE1 axis, NK cells express the cognate receptors for various nociceptor-produced mediators. It is therefore possible that these mediators modulate NK cell activity. This paper presents a co-culture method to investigate the biology of the nociceptor neuron-NK cell interaction. This approach will help advance the understanding of how nociceptor neurons modulate innate immune cell responses to injury, infection, or malignancy.

Protocol

The Institutional Animal Care and Use Committees of Université de Montréal (#22053, #22054) approved all animal procedures. See Table 1 for a list of solutions and their composition and the Table of Materials for a list of materials, equipment, and reagents used in this protocol.

1. NK cell isolation, culture, and stimulation

1. Generate nociceptor neuron intact (littermate control; TRPV1^wt::DTA^fl/wt) and ablated (TRPV1^cre::DTA^fl/wt) mice by crossing lox-stop-lox-diphtheria toxin mice (DTA^fl/fl) with TRPV1^cre/wt mice.
2. Using CO₂ inhalation, euthanize a naïve littermate control (TRPV1^wt::DTA^fl/wt) mouse.
3. Collect the spleen in a 1.5 mL microcentrifuge tube containing 500 µL of sterile phosphate-buffered saline (PBS).
4. Homogenize the spleen using a pestle.
5. Dilute the cells with 1 mL of sterile PBS.
6. Filter the mixture through a 50 µm cell strainer into a 15 mL conical tube.
7. Top up the volume (10 mL) with sterile PBS.
8. Collect 10 µL and count the cells using a hemocytometer.
9. Centrifuge the cells (500 × g, 5 min) and remove the supernatant.
10. Resuspend the cells at a concentration of 10⁸ cells/mL in supplemented RPMI 1640 medium.
11. Follow the manufacturer's instructions to magnetically purify spleen NK cells using a mouse NK cell isolation kit. Confirm NK cell purity using flow cytometry¹¹.
12. Collect 10 µL and count the cells using a hemocytometer.
13. Centrifuge the cells (500 × g, 5 min) and remove the supernatant.
14. Resuspend the NK cells in supplemented RPMI 1640 culture medium (containing IL-2 and IL-15).
15. Culture 2 × 10⁶ NK cells/mL in a 96-well U-bottom plate for 48 h.

2. DRG neuron isolation and culture

1. At 24 h prior to the end of the NK cell stimulation (step 1.15), coat a 96-well plate with 100 µL/well of laminin (1 ng/mL) and incubate for 45 min (37 °C).
2. After incubation, remove the solution and allow the wells to air-dry in a biosafety cabinet.
3. Using CO₂ inhalation, euthanize nociceptor neuron intact (littermate control; TRPV1^wt::DTA^fl/wt) or ablated (TRPV1^cre::DTA^fl/wt) mice.
   NOTE: CO₂ inhalation is preferred to cervical dislocation as it avoids disrupting the spinal nerves connected to the DRG.
4. Secure the mouse on the board in a prone position, lift the skin, and incise the skin along the dorsal column. Refer to Perner et al. for a detailed video¹².
5. Cut off the lumbosacral joint and separate the sacrum from the lumbar spine with scissors.
6. Separate the spine by cutting the muscles and ribs on both sides of the spine in the cranial direction until the base of the skull is reached.
7. Using scissors, cut off the spine at the atlanto-occipital joint.
8. Remove muscle and fatty tissue from the spine.
9. Pin and open the vertebral column to remove the spinal cord and gain access to the DRG. Look for the DRG in the intervertebral foramina connected to the spinal cord through the dorsal root but separated from the meninges.
10. Harvest the DRGs into a 15 mL conical tube filled with 10 mL of ice-cold supplemented DMEM.
11. Centrifuge the preparation (200 × g, 5 min, room temperature) and remove the supernatant.
12. Add 250 µL of PBS containing Collagenase IV (1 mg/mL) and Dispase II (2.4 U/mL).
13. Incubate the DRG with Collagenase IV/Dispase II (C/D) solution (80 min, 37 °C, mild agitation). When pooling ganglia from several mice, maintain a ratio of 125 µL of C/D solution per ganglion.
14. To inactivate the enzymes, add 5 mL of supplemented DMEM medium.
15. Centrifuge the solution (200 × g, 5 min) and gently remove the supernatant using a pipette.
16. To avoid unwanted cell loss, leave ~100 µL of the supernatant.
17. Add 1 mL of supplemented DMEM medium.
18. Using a pipette gun and three glass Pasteur pipettes of decreasing sizes, gently triturate (~10 up/down per Pasteur pipette size) the DRG into a single-cell preparation.
19. In a biosafety cabinet, dilute bovine serum albumin (BSA) in sterile PBS to a final concentration of 15%. Store 1 mL aliquots at −20 °C.
20. Create a BSA gradient in a 15 mL conical tube by adding 2 mL of sterile PBS and slowly dispensing 1 mL of 15% BSA solution at the bottom of the tube. Avoid disrupting the gradient by gently removing the pipette.
21. Using a P200 pipette, slowly pipette the triturated ganglia suspension (which contains the neurons) onto the side of the tube into the gradient.
22. Centrifuge the neuron-containing BSA gradient (200 × g, 12 min, room temperature). Set the acceleration and deceleration of the centrifuge to the minimum speed.
    NOTE: After centrifugation, the neurons will be at the bottom of the tube while the cell debris will be trapped in the BSA gradient.
23. Gently remove all of the supernatant using a pipette.
24. Resuspend the cells in 500 µL of Neurobasal.
25. Plate 10⁴ neurons per well (200 µL of neurobasal/well) in a laminin-coated, flat-bottom 96-well plate.
    NOTE: On average, an investigator will be able to fill ~8 wells per mouse.
26. Culture the neurons (37 °C, overnight) to allow attachment.

3. Co-culture and flow cytometry

1. Slowly remove the neurobasal from the neuron culture.
2. After 48 h stimulation with IL-2 and IL-15 (see steps 1.14-1.15), resuspend the NK cells and add 10⁵ NK cells/well to the neuron culture (96-well flat bottom plate).
   NOTE: On average, the investigator will be able to fill ~6 wells per mouse.
3. Co-culture the cells in supplemented neurobasal MX (37 °C, 48 h).
4. Collect the cells, wash with PBS (3x), and centrifuge (500 × g, 5 min, 4 °C).
5. Discard the supernatant and stain the cells with Viability Dye eFlour-780 (1:1,000, 15 min, 4 °C).
6. Collect the cells, wash with PBS (3x), and centrifuge (500 × g, 5 min, 4 °C).
7. Block nonspecific sites on the cells with CD16/32 (1:100, 15 min, 4 °C).
8. Collect the cells, wash with PBS (3x), and centrifuge (500 × g, 5 min, 4 °C).
9. Stain (15 min, 4 °C) the cells with BV421 anti-NK-1.1 (1:100), fluorescein isothiocyanate (FITC) anti-NKp46 (1:100), and phycoerythrin (PE) anti-GM-CSF (1:100).
10. Collect the cells, wash with PBS (3x), and centrifuge (500 × g, 5 min, 4 °C).
11. Discard the supernatant, resuspend the cells in FACS buffer (500 µL) and immunophenotype the NK cells by flow cytometry¹¹. See Figure 1A for the gating strategy.

Results

NK cells were magnetically purified from littermate control (TRPV1^wt::DTA^fl/wt) mice splenocytes and stimulated (48 h) with IL-2 and IL-15. The NK cells were then cultured alone or co-cultured with DRG neurons harvested from nociceptor neuron intact (littermate control; TRPV1^wt::DTA^fl/wt) or ablated (TRPV1^cre::DTA^fl/wt) mice. The cells were then exposed to the TRPV1 agonist capsaicin (1 µM) or its vehicle. After 24 h of co-culture, the NK cells were F...

Discussion

Davies et al.¹¹ found that injured neurons upregulate RAE1. Via cell-cell contact, NKG2D-expressing NK cells were then able to identify and eliminate RAE1⁺ neurons, which in turn limit chronic pain¹¹. Given that NK cells also express various neuropeptide receptors, and that those neuropeptides are known for their immunomodulatory capabilities, it appears increasingly important to study the interaction between NK cells and nociceptor neurons in vitro<...

Materials

Name	Company	Catalog Number	Comments
Anti-mouse CD16/32	Jackson Laboratory	Cat no: 017769
B-27	Jackson Laboratory	Cat no: 009669
Bovine Serum Albumin (BSA) culture grade	World Precision Instruments	Cat no: 504167
BV421 anti-mouse NK-1.1	Fisher Scientific	Cat no: 12430112
Cell strainer (50 μm)	Fisher Scientific	Cat no: A3160702
Collagenase IV	Fisher Scientific	Cat no: 15140148
Diphteria toxinfl/fl	Fisher Scientific	Cat no: SH3057402
Dispase II	Fisher Scientific	Cat no: 13-678-20B
Dulbecco's Modified Eagle Medium (DMEM)	Fisher Scientific	Cat no: 07-200-95
EasySep Mouse NK Cell Isolation Kit	Sigma	Cat no: CLS2595
Ethylenediaminetetraacetic acid (EDTA)	Sigma	Cat no: C0130
FACSAria III	Sigma	Cat no: 04942078001
Fetal bovine serum (FBS)	Sigma	Cat no: 806552
FITC anti-mouse NKp46	Sigma	Cat no: L2020
Flat bottom 96-well plate	Sigma	Cat no: 03690
Glass Pasteur pipette	Sigma	Cat no: 470236-274
Glial cell line-derived neurotrophic factor (GDNF)	VWR	Cat no: 02-0131
Laminin	Cedarlane	Cat no: 03-50/31
L-Glutamine	Gibco	Cat no: A14867-01
Mouse recombinant IL-15	Gibco	Cat no: 22400-089
Mouse recombinant IL-2	Gibco	Cat no: 21103-049
Nerve Growth Factor (NGF)	Life Technologies	Cat no: 13257-019
Neurobasal media	PeproTech	Cat no: 450-51-10
PE anti-mouse GM-CSF	PeproTech	Cat no: 212-12
Penicillin and Streptomycin	PeproTech	Cat no: 210-15
Pestles	Stem Cell Technology	Cat no: 19855
Phosphate Buffered Saline (PBS)	Biolegend	Cat no: 108732	Clone PK136
RPMI 1640 media	Biolegend	Cat no: 137606	Clone 29A1.4
TRPV1Cre	Biolegend	Cat no: 505406	Clone MP1-22E9
Tweezers and dissection tools.	Biolegend	Cat no: 65-0865-14
U-Shaped-bottom 96-well plate	Biolegend	Cat no: 101319
Viability Dye eFlour-780	Becton Dickinson